Cagrilintide Safety and Risks As with any investigational peptide , cagrilintide should be used with clinical caution , particularly in populations with pre-existing endocrine or gastrointestinal disorders
Second, the development of new drugs requires additional and more detailed preclinical and clinical studies to determine whether long-term use is biotoxic, whether the drug has adverse effects on other peripheral organs or whether the drug candidate has a real therapeutic effect on the patients
These side effects are most pronounced during the dose escalation phase when your body is still adapting to the medication
Further research is necessary to explore these possibilities
It is difficult when we engineered a food system that broke human appetite regulation at scale, flooded it with ultra-processed calories, removed physical labor from most jobs, and then acted surprised when 42% of the population became obese
With less salt being pulled back, more salt leaves your body